On November 20, 2023, Braskem, a prominent biopolymer producer, was granted a substantial Research, Demonstration, and Development (RD&D) fund of $671,000 from the REMADE Institute. The REMADE Institute is a public-private partnership established by the United States Department of Energy. This grant will serve as a catalyst for Braskem’s pioneering efforts in developing a revolutionary approach to achieving circularity in multi-layer plastic packaging.
The primary focus of this project is to leverage advanced manufacturing technology in order to produce sustainable and recyclable multilayer plastic films that possess exceptional properties suitable for demanding applications. Braskem America, in collaboration with the University of Massachusetts Lowell, Dow Chemical, and Aquapak, will spearhead this groundbreaking initiative.
Through this partnership, Braskem and its collaborators aim to contribute to the United States’ transition towards a circular economy. Their overarching goal is to expedite the nation’s progress towards a more sustainable economy and society.
By securing this RD&D grant, Braskem and its partners are poised to make significant strides in reshaping the future of plastic packaging. Their innovative approach holds the potential to revolutionize the industry and pave the way for a more environmentally conscious and resource-efficient future.
Braskem S.A.
BAK
Buy
Updated on: 30/11/2023
Financial Health
Healthy
Debt to equity ratio: Strong Buy
Price to earnings ratio: Strong Sell
Price to book ratio: Strong Buy
DCF: Strong Buy
ROE: Sell
BAK Industries: Stable Stock Performance but Concerning Financial Indicators and Projections
BAK Industries, a specialty chemicals company based in Butanta, Sao Paulo, experienced a relatively stable stock performance on November 20, 2023. The stock opened at $8.26, slightly higher than the previous day’s close of $8.19. Throughout the day, the stock fluctuated within a narrow range, reaching a high of $8.32 and a low of $8.25. The trading volume for the day was 117,978 shares, significantly lower than the average volume of 745,645 shares over the past three months.
With a market capitalization of $1.4 billion, BAK Industries is a mid-sized company in the process industries sector. However, the company’s recent financial performance has been concerning. In the last year, BAK Industries experienced a significant decline in earnings growth, with a negative growth rate of -102.51%. The company’s revenue growth also declined by 4.52% during the same period.
Looking forward, analysts forecast a negative earnings growth rate of -30.25% for the next five years. This indicates that BAK Industries may face challenges in generating profits and sustaining its business in the coming years. The company’s negative earnings growth in the past and the projected decline in the future could be a cause for concern for investors.
The company’s financial indicators also raise some red flags. BAK Industries has a negative net profit margin of -0.35%, indicating that the company is not generating significant profits relative to its revenue. Additionally, the company’s price-to-earnings (P/E) ratio is listed as “NM,” which means it is not meaningful. This could be due to negative earnings or other factors that make the P/E ratio irrelevant.
In terms of valuation, BAK Industries has a low price-to-sales ratio of 0.20, which suggests that the stock may be undervalued compared to its revenue. The price-to-book ratio of 2.34 indicates that the stock is trading at a higher price relative to its book value.
Despite the concerning financial indicators, BAK Industries does not have any executives listed, which could raise questions about the company’s leadership and management structure. The next reporting date for the company is scheduled for March 14, 2024, when investors will have more insight into the company’s financial performance.
Overall, BAK Industries’ stock performance on November 20, 2023, was relatively stable, but the company’s financial indicators and projections suggest potential challenges ahead. Investors should carefully consider the company’s negative earnings growth, declining revenue, and other financial metrics before making any investment decisions.
Braskem SA (BAK) Stock Price Forecast and Analysis: November 2023
On November 20, 2023, Braskem SA (BAK) had a median target price of 10.78, according to 8 analysts offering 12-month price forecasts. The high estimate was 16.27, while the low estimate was 8.16. This median estimate represented a 29.98% increase from the last price of 8.29.
The consensus among the 8 polled investment analysts was to hold stock in Braskem SA. This rating had remained steady since October, when it was unchanged from a hold rating. This suggests that the analysts did not see any significant changes in the company’s prospects or performance.
Looking at the current quarter’s earnings per share, Braskem SA reported $0.15. This indicates the company’s profitability for the period. Additionally, the company’s sales for the quarter were $3.8 billion, reflecting the revenue generated during this time.
Investors and analysts will be eagerly awaiting the reporting date for this quarter, which is March 14. This will provide more detailed information about Braskem SA’s financial performance and may influence future price forecasts and investment recommendations.
It is worth noting that these forecasts and ratings are based on the information available at the time and are subject to change. Investors should conduct their own research and analysis before making any investment decisions.
Discussion about this post